These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9664234)

  • 41. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: growth and clinical parameters.
    Rotter BA; Thompson BK; Prelusky DB; Trenholm HL; Stewart B; Miller JD; Savard ME
    Nat Toxins; 1996; 4(1):42-50. PubMed ID: 8680753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
    Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
    Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of intravenous fumonisin B1 in rabbits: nephrotoxicity and sphingolipid alterations.
    Gumprecht LA; Marcucci A; Weigel RM; Vesonder RF; Riley RT; Showker JL; Beasley VR; Haschek WM
    Nat Toxins; 1995; 3(5):395-403. PubMed ID: 8581326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of fumonisin B1 on developing chick embryos: correlation between de novo sphingolipid biosynthesis and gross morphological changes.
    Zacharias C; van Echten-Deckert G; Wang E; Merrill AH; Sandhoff K
    Glycoconj J; 1996 Apr; 13(2):167-75. PubMed ID: 8737241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of the mitogenic and carcinogenic action of fumonisin B1, a mycotoxin.
    Wolf G
    Nutr Rev; 1994 Jul; 52(7):246-7. PubMed ID: 8090377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA damage in astrocytes exposed to fumonisin B1.
    Galvano F; Campisi A; Russo A; Galvano G; Palumbo M; Renis M; Barcellona ML; Perez-Polo JR; Vanella A
    Neurochem Res; 2002 Apr; 27(4):345-51. PubMed ID: 11958538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of fumonisin B1-contaminated feeds on weanling angora goats.
    Gurung NK; Rankins DL; Shelby RA; Goel S
    J Anim Sci; 1998 Nov; 76(11):2863-70. PubMed ID: 9856397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B(1) as an example.
    Dragan YP; Bidlack WR; Cohen SM; Goldsworthy TL; Hard GC; Howard PC; Riley RT; Voss KA
    Toxicol Sci; 2001 May; 61(1):6-17. PubMed ID: 11294969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.
    Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH
    J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxicity of culture material of Fusarium verticillioides strain MRC 826 to nonhuman primates.
    Gelderblom WC; Seier JV; Snijman PW; Van Schalkwyk DJ; Shephard GS; Marasas WF
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):267-76. PubMed ID: 11359695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of fumonisin B1 in pregnant rats. Part 2.
    Collins TF; Sprando RL; Black TN; Shackelford ME; Laborde JB; Hansen DK; Eppley RM; Trucksess MW; Howard PC; Bryant MA; Ruggles DI; Olejnik N; Rorie JI
    Food Chem Toxicol; 1998 Aug; 36(8):673-85. PubMed ID: 9734718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
    He Q; Riley RT; Sharma RP
    Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mechanistic approach to modelling the risk of liver tumours in mice exposed to fumonisin B1 in the diet.
    Kodell RL; Young JF; Delongchamp RR; Turturro A; Chen JJ; Gaylor DW; Howard PC; Zheng Q
    Food Addit Contam; 2001 Mar; 18(3):237-53. PubMed ID: 11304033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous fumonisin B1 induces cell proliferation and apoptosis in the rat.
    Lim CW; Parker HM; Vesonder RF; Haschek WM
    Nat Toxins; 1996; 4(1):34-41. PubMed ID: 8680752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
    Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
    J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fumonisin B(1) is hepatotoxic and nephrotoxic in milk-fed calves.
    Mathur S; Constable PD; Eppley RM; Waggoner AL; Tumbleson ME; Haschek WM
    Toxicol Sci; 2001 Apr; 60(2):385-96. PubMed ID: 11248152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
    Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks.
    Tardieu D; Tran ST; Auvergne A; Babilé R; Benard G; Bailly JD; Guerre P
    Chem Biol Interact; 2006 Mar; 160(1):51-60. PubMed ID: 16412405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1.
    Sharma RP; Bhandari N; He Q; Riley RT; Voss KA
    Toxicology; 2001 Feb; 159(1-2):69-79. PubMed ID: 11250056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.